These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 421089)

  • 1. Assessment of renal concentrating ability.
    Curtis JR; Donovan BA
    Br Med J; 1979 Feb; 1(6159):304-5. PubMed ID: 421089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of renal concentrating ability with DDAVP and pitressin.
    Herbai G; Ljunghall S
    Scand J Urol Nephrol; 1983; 17(1):69-71. PubMed ID: 6867627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desamino arginine vasopressin (DDAVP) as a diagnostic agent.
    Somerfield SD; Hocken AG
    N Z Med J; 1977 Nov; 86(600):472-3. PubMed ID: 343010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of renal concentrating ability in lithium-treated patients. Comparison of long-term dehydration with administration of a vasopressin analogue.
    Vestergaard P; Hansen HE
    Acta Psychiatr Scand; 1980 Feb; 61(2):152-6. PubMed ID: 7361586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DDAVP (1-desamino-8-D-arginine-vasopressin) treatment of lithium-induced polyuria in the rat.
    Christensen S
    Scand J Clin Lab Invest; 1980 Apr; 40(2):151-7. PubMed ID: 7256183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDAVP test for assessment of renal concentrating capacity in infants and children.
    Monnens L; Smulders Y; van Lier H; de Boo T
    Nephron; 1981; 29(3-4):151-4. PubMed ID: 7329489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experiences with intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP). Use in a simple test of renal concentrating ability].
    Tuschy U; Szeszat S; Rindfleisch U
    Z Gesamte Inn Med; 1984 Jun; 39(11):265-8. PubMed ID: 6475171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-desamino-8-D-arginine vasopressin (DDAVP) concentration test.
    Radó JP
    Am J Med Sci; 1978; 275(1):43-52. PubMed ID: 665711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal DDAVP-test in the study of renal concentrating capacity in children with recurrent urinary tract infections.
    Abyholm G; Monn E
    Eur J Pediatr; 1979 Mar; 130(3):149-54. PubMed ID: 421696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous and intranasal administration of 1-deamino-8-d-arginine vasopressin in the assessment of renal concentration capacity.
    Tryding N; Sterner G; Berg B; Harris A; Lundin S
    Nephron; 1987; 45(1):27-30. PubMed ID: 3808145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal DDAVP test in children.
    Helin I
    J Urol; 1982 Jan; 127(1):78-9. PubMed ID: 7057511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on kidney function in subjects exposed to organic solvents. II. The effect of desmopressin in a concentration test and the effect of exposure to organic solvents on renal concentrating ability.
    Askergren A; Allgën LG; Bergström J
    Acta Med Scand; 1981; 209(6):485-8. PubMed ID: 7257866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adiuretin (DDAVP) test for renal concentrating ability in infants].
    Lehotská V; Lichardus B; Némethová V; Skultétyová M
    Cesk Pediatr; 1981 Jun; 36(6):324-7. PubMed ID: 7273216
    [No Abstract]   [Full Text] [Related]  

  • 14. Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment.
    Zittema D; Boertien WE; van Beek AP; Dullaart RP; Franssen CF; de Jong PE; Meijer E; Gansevoort RT
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):906-13. PubMed ID: 22516290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Possibilities in the determination of kidney concentrating ability as based on the DDAVP [deamino-(8-D-arginine)-vasopressin] test].
    Nádvorníková H; Schück O; Cort JH
    Vnitr Lek; 1978 Oct; 24(10):1026-31. PubMed ID: 706183
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences with intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP). Use in the diagnosis of hypophyseal function].
    Tuschy U; Szeszat S; Meinhold J
    Z Gesamte Inn Med; 1983 Sep; 38(17):475-7. PubMed ID: 6636917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydronephrosis: prevention by restoration of urinary concentrating ability using desamino-8D-arginine vasopressin (DDAVP) in Brattleboro rats.
    Laycock JF; Barrett MC; Woodrow DF
    Int J Exp Pathol; 1991 Oct; 72(5):581-7. PubMed ID: 1742211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DDAVP test for renal concentration capacity. Age-related reference intervals.
    Tryding N; Berg B; Ekman S; Nilsson JE; Sterner G; Harris A
    Scand J Urol Nephrol; 1988; 22(2):141-5. PubMed ID: 3206218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Water intoxication in infants caused by the urine concentration test with vasopressin analogue (DDAVP).
    Koskimies O; Pylkkänen J; Vilska J
    Acta Paediatr Scand; 1984 Jan; 73(1):131-2. PubMed ID: 6702442
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of the renal concentration capacity following intravenous administration of dDAVP in healthy humans.
    Faerch M; Schroeder MK; Mahler BT; Christensen JH; Kamperis K; Rittig S
    Scand J Clin Lab Invest; 2018; 78(1-2):114-119. PubMed ID: 29361858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.